Digestive Enzymes

NutraPedia - Evidence-Based Supplement Research

Back to Table of Contents
Health Goals: digestion inflammation detox

Research Overview

Recent research on digestive enzymes has concentrated on how diet-derived bioactives and microbiome-targeted interventions modulate enzymatic digestion and downstream health outcomes. The most studied areas in the studies reviewed here are (i) inhibition of key digestive enzymes by plant polyphenols/phenolics (e.g., α-amylase, pepsin, trypsin, α-chymotrypsin), including mechanistic work on protein–polyphenol binding; (ii) nutraceutical strategies in animal production (notably poultry) that aim to enhance digestive enzyme activity and nutrient transport through botanical products and essential oils; and (iii) probiotic supplementation in aquaculture, emphasizing microbial contributions of exogenous enzymes and stimulation of host endogenous enzyme activity, particularly in early life stages. A related, increasingly integrated theme is the role of the gut microbiota in processing otherwise indigestible substrates (e.g., polysaccharides) and how this microbial metabolism indirectly shapes digestive efficiency and host physiology.

The strongest evidence supports that polyphenols can directly interact with digestive enzymes and reduce catalytic activity under certain conditions, with multiple complementary approaches (in vitro kinetics, spectroscopy, and in silico docking/simulation) converging on active-site binding and often competitive inhibition for specific purified compounds. At the applied nutrition level, reviews in poultry and aquaculture consistently report associations between botanical products or probiotics and improved feed utilization, gut function, and performance metrics, plausibly mediated by altered enzyme activity and microbiota composition; however, these findings are more heterogeneous and context-dependent (species, dose, formulation, life stage). The evidence also supports that microbiota-mediated metabolism is essential for utilization of non-digestible polysaccharides, with downstream effects on short-chain fatty acid production and host health, underscoring that “digestive capacity” is a combined host–microbe property rather than solely a function of human or animal enzymes.

Key gaps include translating enzyme inhibition findings into real-world dietary and clinical relevance: many studies rely on simplified in vitro systems, limited panels of enzymes/compounds, and conditions that may not reflect gastrointestinal complexity (food matrix effects, dynamic pH, bile, proteolysis, and competing proteins). More research is needed to quantify dose–response relationships and identify vulnerable subpopulations (e.g., risks linked to polyphenol supplementation, iron absorption interference, drug interactions, and potential microbiome disruption), using well-controlled human studies and standardized assays. In production settings, stronger causal evidence is needed to link specific botanicals/probiotics to defined enzymatic mechanisms (host gene expression, enzyme secretion/activity, and nutrient transporter regulation) while also characterizing safety boundaries, since high-dose probiotic administration has been reported to cause adverse effects via microbiota imbalance. Finally, integrative multi-omics and standardized reporting would help connect enzyme activity changes to clinically meaningful endpoints (glycemic control, nutrient status, gastrointestinal function) across humans and animal models.

1. What conditions has Digestive Enzymes been studied for?

  • Metabolic health / glycemic control (dietary context): Plant polyphenols have been studied for their ability to inhibit carbohydrate-digesting enzymes (e.g., α-amylase, α-glycosidase), a mechanism used to lower the glycemic impact of foods (e.g., “low GI noodles” concept).

  • Digestive function and feed utilization in animals (poultry, aquaculture): Botanical nutraceuticals and probiotics have been studied for activating digestive enzymes, improving digestion/absorption, and supporting growth and productivity in poultry and shrimp/fish.

  • Gut health and intestinal disorders (primarily animal literature in these studies): Probiotics in aquafeed are discussed in relation to gut maturation, prevention of intestinal disorders, and improved digestive enzyme activity in the gut.

  • Pancreatic disease/regeneration (enzyme-producing organ context): One abstract discusses pancreatic regeneration (exocrine pancreas as a reservoir of digestive enzymes), but it is focused on β-cell replacement/regeneration strategies rather than digestive enzyme supplementation.

  • Interactions affecting nutrient absorption and digestion (human health risk context): Reviews highlight that polyphenols can block iron uptake and may inhibit digestive enzymes and alter microbiota—relevant to digestion/nutrient status rather than a specific “condition treated by enzymes.”

2. Does it work in treating those conditions? Summarize the evidence.

  • Lowering glycemic impact via enzyme inhibition (food/ingredient strategy): The low-GI noodle review states that plant polyphenols can reduce glycemic index by hindering interaction between digestive enzymes and starch, thereby reducing enzymatic activity. This supports a plausible mechanism for lowering post-meal glucose response, but the study is a review of approaches and does not provide clinical effect sizes for humans.

  • Direct evidence of digestive enzyme inhibition by specific polyphenols (mechanistic): An in vitro/in silico study reports that curcumin, diosmin, morin, and 2',3',4'-trihydroxychalcone showed favorable active-site interactions with α-amylase, pepsin, trypsin, and α-chymotrypsin, reducing enzyme activity; inhibition was described as competitive in that study. A separate review notes many enzyme–polyphenol interactions are non-competitive and mediated by non-covalent binding forces, highlighting that inhibition mode may vary by compound/enzyme and study method.

  • Improving digestion/feed utilization in animals (supportive but not directly human-applicable): The poultry nutraceutical review describes botanical products as “activating digestive enzymes” and restoring microbiota balance, with reported production improvements (e.g., broiler body weight ~7%, egg production ~15%). The aquafeed probiotic review describes probiotics increasing feed consumption/absorption partly by releasing digestive enzymes and stimulating endogenous enzyme production, especially in shrimp larvae/early post-larvae. These findings support efficacy in animal production settings, but they do not establish efficacy of digestive enzyme supplements for human diseases.

  • Pancreatic regeneration: The pancreas abstract supports that the exocrine pancreas is a digestive enzyme reservoir, but it does not test digestive enzyme therapy; it focuses on β-cell replacement/regeneration for diabetes.

Overall, within these studies, the strongest “works” evidence is mechanistic (polyphenols inhibiting digestive enzymes) and animal-production outcomes (botanicals/probiotics improving digestion and growth). Evidence for digestive enzyme supplementation treating specific human conditions is not directly provided in the supplied studies.

3. What health benefits does it have?

  • Potential glycemic benefit via reduced starch digestion: Plant polyphenols can reduce enzymatic breakdown of starch by interfering with digestive enzyme–starch interactions, a strategy used to lower the glycemic index of foods (review on low-GI noodles).

  • Improved digestion and nutrient utilization (animal evidence): Probiotics in aquafeed are described as improving feed consumption and absorption by releasing digestive enzymes and stimulating endogenous enzyme activity, alongside gut maturation and disease resistance. Botanical nutraceuticals in poultry are described as activating digestive enzymes and restoring microbiota balance, supporting health and production.

  • Microbiota-related benefits (contextual): Multiple studies emphasize microbiota balance as a downstream target (botanical products “restoring microbiota balance”; polysaccharides promoting probiotics and SCFA production). While not “digestive enzymes” per se, these mechanisms are tightly linked to digestion and gut function.

4. Does it have any downsides or side effects?

  • Polyphenol-related inhibition of digestive enzymes (potentially undesirable): A human-health-focused review warns that polyphenols—especially in supplement form—can have harmful effects in certain situations, including inhibition of digestive enzymes. Mechanistic studies support that specific polyphenols can bind digestive enzymes and reduce their activity (in vitro/in silico), which could theoretically impair digestion depending on dose, timing, and individual context.

  • Reduced iron absorption: The same review highlights polyphenols’ ability to block iron uptake, which may be harmful in vulnerable subpopulations (e.g., those at risk of iron deficiency).

  • Microbiota disruption at high probiotic doses (animal evidence): The aquafeed probiotic review notes some studies found adverse effects at high concentrations, possibly due to gut microbiota imbalance from replenished commensal probiotics.

  • Drug and hormonal interactions; pro-oxidant/genotoxic concerns (polyphenol supplements): The polyphenol safety review also describes potential interactions with drugs, impacts on hormonal balance, and pro-oxidative activity with mutagenic/carcinogenic/genotoxic effects under certain conditions—presented as risks warranting public awareness, particularly for supplement use.

  • Animal production caveat: A poultry-focused review notes that high quantities of polyphenols can have “unknown and occasionally unfavorable impacts” on digestive tract health, nutrient assimilation, digestive enzyme activity, and vitamin/mineral assimilation.

Important limitation: many of these downsides are discussed in the context of polyphenol supplementation (not digestive enzyme supplements), and several efficacy/safety findings are from in vitro or animal literature rather than controlled human trials.

5. Is it beneficial or harmful for any genetic variations (pharmacogenomics)?

The studies reviewed here do not report pharmacogenomic findings (i.e., specific genetic variants that predict benefit or harm) for digestive enzymes, probiotics, botanical nutraceuticals, or polyphenol–digestive enzyme interactions.

  • What can be inferred (limited): The polyphenol safety review emphasizes “vulnerable subpopulations” (e.g., those affected by iron uptake inhibition or drug interactions), but it does not identify genetic markers.

  • Evidence gap: Based on these studies alone, no genotype-guided recommendations can be made for digestive enzyme-related interventions.

References

  1. Possible Side Effects of Polyphenols and Their Interactions with Medicines.
    Aleksandra Duda-Chodak, Tomasz Tarko (2023) - Molecules (Basel, Switzerland)
  2. Application of botanical products as nutraceutical feed additives for improving poultry health and production.
    Karim El-Sabrout, Ayman Khalifah, Birendra Mishra (2023) - Veterinary world
  3. Probiotics, lactic acid bacteria and bacilli: interesting supplementation for aquaculture.
    E Ringø, H Van Doan, S H Lee, M Soltani, S H Hoseinifar, R Harikrishnan, S K Song (2020) - Journal of applied microbiology
  4. Changes in bioactive compounds and antioxidant activity of plant-based foods by gastrointestinal digestion: a review.
    Sunantha Ketnawa, Florencio Collado Reginio, Sukanya Thuengtung, Yukiharu Ogawa (2022) - Critical reviews in food science and nutrition
  5. Pancreas regeneration.
    Qiao Zhou, Douglas A Melton (2018) - Nature
  6. Study of an inhibitory effect of plant polyphenolic compounds against digestive enzymes using bench-working experimental evidence predicted by molecular docking and dynamics.
    Kaushal Vyas, Supraja Prabaker, Dhamodharan Prabhu, Meenakumari Sakthivelu, Sundararaj Rajamanikandan, Palaniyandi Velusamy, Chia-Hung Su, Subash C B Gopinath, Raman Pachaiappan (2024) - International journal of biological macromolecules
  7. The structure-function relationships and interaction between polysaccharides and intestinal microbiota: A review.
    Hongkun Xue, Yingqi Tang, Min Zha, Kaifang Xie, Jiaqi Tan (2025) - International journal of biological macromolecules
  8. Polyphenolic Compounds and Digestive Enzymes: In Vitro Non-Covalent Interactions.
    Alejandra I Martinez-Gonzalez, Ángel G Díaz-Sánchez, Laura A de la Rosa, Claudia L Vargas-Requena, Ismael Bustos-Jaimes, And Emilio Alvarez-Parrilla (2017) - Molecules (Basel, Switzerland)
  9. Precise oral delivery systems for probiotics: A review.
    Ya Luo, Cristabelle De Souza, Mythili Ramachandran, Shaolei Wang, Huaxi Yi, Zhao Ma, Lanwei Zhang, Kai Lin (2022) - Journal of controlled release : official journal of the Controlled Release Society
  10. Low glycemic index noodle and pasta: Cereal type, ingredient, and processing.
    Congli Cui, Yong Wang, Jian Ying, Weibiao Zhou, Dong Li, Li-Jun Wang (2024) - Food chemistry
  11. The efficacy of polyphenols as an antioxidant agent: An updated review.
    Mohamed E Abd El-Hack, Maria Cristina de Oliveira, Youssef A Attia, Mahmoud Kamal, Najlaa H Almohmadi, Islam M Youssef, Norhan E Khalifa, Mahmoud Moustafa, Mohammed Al-Shehri, Ayman E Taha (2023) - International journal of biological macromolecules
  12. Milk and Its Derivatives as Sources of Components and Microorganisms with Health-Promoting Properties: Probiotics and Bioactive Peptides.
    Laura Quintieri, Francesca Fanelli, Linda Monaci, Vincenzina Fusco (2024) - Foods (Basel, Switzerland)
  13. Pancreatic endocrine and exocrine signaling and crosstalk in physiological and pathological status.
    Chenglin Hu, Yuan Chen, Xinpeng Yin, Ruiyuan Xu, Chenxue Yin, Chengcheng Wang, Yupei Zhao (2025) - Signal transduction and targeted therapy
  14. Starch digestibility: past, present, and future.
    Luis A Bello-Perez, Pamela C Flores-Silva, Edith Agama-Acevedo, Juscelino Tovar (2020) - Journal of the science of food and agriculture
  15. Proanthocyanidins at the gastrointestinal tract: mechanisms involved in their capacity to mitigate obesity-associated metabolic disorders.
    Wei Zhu, Patricia I Oteiza (2024) - Critical reviews in food science and nutrition
  16. Comprehensive Nutritional and Dietary Intervention for Autism Spectrum Disorder-A Randomized, Controlled 12-Month Trial.
    James B Adams, Tapan Audhya, Elizabeth Geis, Eva Gehn, Valeria Fimbres, Elena L Pollard, Jessica Mitchell, Julie Ingram, Robert Hellmers, Dana Laake, Julie S Matthews, Kefeng Li, Jane C Naviaux, Robert K Naviaux, Rebecca L Adams, Devon M Coleman, David W Quig (2018) - Nutrients
  17. Role of Probiotics in health improvement, infection control and disease treatment and management.
    A A Amara, A Shibl (2015) - Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society
  18. Strawberry as a functional food: an evidence-based review.
    Arpita Basu, Angel Nguyen, Nancy M Betts, Timothy J Lyons (2014) - Critical reviews in food science and nutrition
  19. Nutrition and Gut Health: Preparation and Efficacy of Resistant Starch.
    Yulong Niu, Li Wang, Huiyi Gong, Shuqing Jia, Qing Guan, Linling Li, Hua Cheng (2025) - Foods (Basel, Switzerland)
  20. Phenolic Bioactives From Plant-Based Foods for Glycemic Control.
    Dipayan Sarkar, Ashish Christopher, Kalidas Shetty (2021) - Frontiers in endocrinology


Related

This article summarizes published research for educational purposes. It is not medical advice. Talk to your doctor before starting, stopping, or changing any supplement or medication.

Want personalized supplement recommendations based on your genetics?
Upload Whole Genome Sequencing (WGS) raw DNA data today!
Or upload raw DNA data to get started with your free analysis!